Literature DB >> 19293244

Incidence and prognosis of > or = 50% symptomatic vertebral or basilar artery stenosis: prospective population-based study.

L Marquardt1, W Kuker, A Chandratheva, O Geraghty, P M Rothwell.   

Abstract

The higher risk of early recurrent stroke after posterior circulation transient ischaemic attack or minor stroke versus after carotid territory events could be due to a greater prevalence of large artery stenosis, but there have been few imaging studies, and the prognostic significance of such stenoses is uncertain. Reliable data are necessary to determine the feasibility of trials of angioplasty and stenting and to inform imaging strategies. In the first-ever population-based study, we determined the prevalence of > or = 50% apparently symptomatic vertebral and basilar stenosis using contrast-enhanced MRA in consecutive patients, irrespective of age, presenting with posterior circulation transient ischaemic attack or minor ischaemic stroke in the Oxford Vascular Study and related this to the 90-day risk of recurrent transient ischaemic attack and stroke. For comparison, we also determined the prevalence of > or = 50% apparently symptomatic carotid stenosis on ultrasound imaging in consecutive patients with carotid territory events. Of 538 consecutive patients, 141/151 (93%) had posterior circulation events and had vertebral and basilar imaging, of whom 37 (26.2%) had > or = 50% vertebral and basilar stenosis, compared with 41 (11.5%) patients with > or = 50% ipsilateral carotid stenosis in 357/387 (92%) patients with carotid events who had carotid imaging (OR = 2.74; 95% CI = 1.67-4.51; P = 0.002). Presence of > or = 50% vertebral and basilar stenosis was unrelated to age, sex or vascular risk factors and, in contrast to > or = 50% carotid stenosis was not associated with evidence of coronary/peripheral atherosclerosis. In patients with posterior circulation events, > or = 50% vertebral and basilar stenosis was associated multiple transient ischaemic attacks at presentation (22% versus 3%; OR = 9.29; 95% CI = 2.31-37.27; P < 0.001) and with a significantly higher 90-day risk of recurrent events (OR = 3.2; 95% CI = 1.4-7.0; P = 0.006), reaching 22% for stroke and 46% for transient ischaemic attack and stroke. The prevalence of > or = 50% vertebral and basilar stenosis in posterior circulation transient ischaemic attack or minor stroke is greater than the prevalence of > or = 50% carotid stenosis in carotid territory events, and is associated with multiple transient ischaemic attacks at presentation and a high early risk of recurrent stroke. Trials of interventional treatment are therefore likely to be feasible, but more data are required on the long-term risk of stroke on best medical treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19293244     DOI: 10.1093/brain/awp026

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  40 in total

Review 1.  Large Artery Atherosclerotic Occlusive Disease.

Authors:  John W Cole
Journal:  Continuum (Minneap Minn)       Date:  2017-02

2.  Hemodynamic Features of Symptomatic Vertebrobasilar Disease.

Authors:  Sepideh Amin-Hanjani; Xinjian Du; Linda Rose-Finnell; Dilip K Pandey; DeJuran Richardson; Keith R Thulborn; Mitchell S V Elkind; Gregory J Zipfel; David S Liebeskind; Frank L Silver; Scott E Kasner; Victor A Aletich; Louis R Caplan; Colin P Derdeyn; Philip B Gorelick; Fady T Charbel
Journal:  Stroke       Date:  2015-05-14       Impact factor: 7.914

3.  High-pitch dual-source CT angiography of supra-aortic arteries: assessment of image quality and radiation dose.

Authors:  A Korn; M Fenchel; B Bender; S Danz; C Thomas; D Ketelsen; C D Claussen; G Moonis; B Krauss; M Heuschmid; U Ernemann; H Brodoefel
Journal:  Neuroradiology       Date:  2012-12-08       Impact factor: 2.804

Review 4.  Cerebral CT angiography and CT perfusion in acute stroke detection: a systematic review of diagnostic value.

Authors:  Akmal Sabarudin; Cantiriga Subramaniam; Zhonghua Sun
Journal:  Quant Imaging Med Surg       Date:  2014-08

5.  Endovascular treatment of the vertebral artery origin stenosis by using the closed-cell, self-expandable Carotid Wallstent.

Authors:  Jun-Kyeung Ko; Chang-Hwa Choi; Lee Hwangbo; Hie-Bum Suh; Tae-Hong Lee; Han-Jin Cho; Sang-Min Sung
Journal:  Interv Neuroradiol       Date:  2020-06-20       Impact factor: 1.610

6.  Effect of Hemodynamics on Stroke Risk in Symptomatic Atherosclerotic Vertebrobasilar Occlusive Disease.

Authors:  Sepideh Amin-Hanjani; Dilip K Pandey; Linda Rose-Finnell; Xinjian Du; DeJuran Richardson; Keith R Thulborn; Mitchell S V Elkind; Gregory J Zipfel; David S Liebeskind; Frank L Silver; Scott E Kasner; Victor A Aletich; Louis R Caplan; Colin P Derdeyn; Philip B Gorelick; Fady T Charbel
Journal:  JAMA Neurol       Date:  2016-02       Impact factor: 18.302

7.  Long-Term Risk of In-Stent Restenosis and Stent Fracture for Extracranial Vertebral Artery Stenting.

Authors:  Man Kwun Andrew Li; Anderson Chun On Tsang; Frederick Chun Pong Tsang; Wai Shing Ho; Raymand Lee; Gilberto Ka Kit Leung; Wai Man Lui
Journal:  Clin Neuroradiol       Date:  2018-07-23       Impact factor: 3.649

8.  Crossover balloon technique for vertebral artery thrombus: a novel method.

Authors:  Vikram Huded; Ratnavalli Ellajosyula; Romnesh de Souza; Syed Moeed Zafer
Journal:  BMJ Case Rep       Date:  2013-02-04

9.  Diagnosis and management of vertebrobasilar insufficiency.

Authors:  Aaron Stayman; Raul G Nogueira; Rishi Gupta
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-04

10.  Transluminal angioplasty and stenting versus conservative treatment in patients with symptomatic basilar artery stenosis : Perspective for future clinical trials.

Authors:  Ilko L Maier; André Karch; Christina Lipke; Daniel Behme; Anastasios Mpotsaris; Christoph Kabbasch; Thomas Liebig; Andrea Faymonville; Arno Reich; Omid Nikoubashman; Jan-Hendrik Buhk; Patrick von Schoenfeld; Werner Weber; Rafael T Mikolajczyk; Mathias Bähr; Michael Knauth; Kai Kallenberg; Jan Liman
Journal:  Clin Neuroradiol       Date:  2016-08-09       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.